CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...
Phase 2
Rock Hill, South Carolina, United States and 63 other locations
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...
Charlotte, North Carolina, United States and 10 other locations
The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (...
Charlotte, North Carolina, United States and 18 other locations
This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with c...
Charlotte, North Carolina, United States and 76 other locations
This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failin...
Charlotte, North Carolina, United States and 50 other locations
To establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic s...
Charlotte, North Carolina, United States and 76 other locations
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
Charlotte, North Carolina, United States and 122 other locations
reduction of cardiovascular death (generally meaning death due to disease of the heart or blood vessels) and total Heart F...
Phase 3
Lancaster, South Carolina, United States and 663 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Statesville, North Carolina, United States and 521 other locations
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Phase 3
Charlotte, North Carolina, United States and 851 other locations
Clinical trials
Research sites
Resources
Legal